Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Redfield

Showing results (921-930 of 1,078) with videos related to

Pageof 108
Sort By:
Viruses|October 29, 2025
Insights into Persistent SARS-CoV-2 Reservoirs in Chronic Long COVIDSwayam Prakash, Sweta Karan, Yassir Lekbach, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 19, 2015
Nature, timing, and severity of complications from ultrasound-guided percutaneous renal transplant biopsyRobert R Redfield, Kasi R McCune, Avinash Rao, et al.
Cardiovascular Research|January 13, 2022
Histologic and proteomic remodeling of the pulmonary veins and arteries in a porcine model of chronic pulmonary venous hypertensionAhmed U Fayyaz, Michael S Sabbah, Surendra Dasari, et al.
Annals of Surgery|July 17, 2015
When Do DCD Donors Die?: Outcomes and Implications of DCD at a High-volume, Single-center OPO in the United StatesJoseph R Scalea, Robert R Redfield, Michael D Rizzari, et al.
Clinical and Experimental Immunology|May 1, 1997
Expansion of restricted cellular immune responses to HIV-1 envelope by vaccination: IL-7 and IL-12 differentially augment cellular proliferative responses to HIV-1J H Kim, J E Loveland, K V Sitz, et al.
American Heart Journal|February 10, 2016
Evaluation of a provocative dyspnea severity score in acute heart failureOmar F AbouEzzeddine, Anuradha Lala, Prateeti P Khazanie, et al.
Human Immunology|February 13, 2016
Current outcomes of chronic active antibody mediated rejection - A large single center retrospective review using the updated BANFF 2013 criteriaRobert R Redfield, Thomas M Ellis, Weixiong Zhong, et al.
American Heart Journal|February 28, 2020
Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved ejection fraction (CAPACITY HFpEF)James E Udelson, Gregory D Lewis, Sanjiv J Shah, et al.
Circulation|January 22, 2025
Evidence-Based Application of Natriuretic Peptides in the Evaluation of Chronic Heart Failure With Preserved Ejection Fraction in the Ambulatory Outpatient SettingYogesh N V Reddy, Atsushi Tada, Masaru Obokata, et al.
JACC. Heart Failure|August 9, 2019
Circulating Neprilysin in Patients With Heart Failure and Preserved Ejection FractionMelissa A Lyle, Seethalakshmi R Iyer, Margaret M Redfield, et al.
Pageof 108

Showing results (921-930 of 1,078) with videos related to

Sort By:
Pageof 108
Viruses|October 29, 2025
Insights into Persistent SARS-CoV-2 Reservoirs in Chronic Long COVIDSwayam Prakash, Sweta Karan, Yassir Lekbach, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 19, 2015
Nature, timing, and severity of complications from ultrasound-guided percutaneous renal transplant biopsyRobert R Redfield, Kasi R McCune, Avinash Rao, et al.
Cardiovascular Research|January 13, 2022
Histologic and proteomic remodeling of the pulmonary veins and arteries in a porcine model of chronic pulmonary venous hypertensionAhmed U Fayyaz, Michael S Sabbah, Surendra Dasari, et al.
Annals of Surgery|July 17, 2015
When Do DCD Donors Die?: Outcomes and Implications of DCD at a High-volume, Single-center OPO in the United StatesJoseph R Scalea, Robert R Redfield, Michael D Rizzari, et al.
Clinical and Experimental Immunology|May 1, 1997
Expansion of restricted cellular immune responses to HIV-1 envelope by vaccination: IL-7 and IL-12 differentially augment cellular proliferative responses to HIV-1J H Kim, J E Loveland, K V Sitz, et al.
American Heart Journal|February 10, 2016
Evaluation of a provocative dyspnea severity score in acute heart failureOmar F AbouEzzeddine, Anuradha Lala, Prateeti P Khazanie, et al.
Human Immunology|February 13, 2016
Current outcomes of chronic active antibody mediated rejection - A large single center retrospective review using the updated BANFF 2013 criteriaRobert R Redfield, Thomas M Ellis, Weixiong Zhong, et al.
American Heart Journal|February 28, 2020
Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved ejection fraction (CAPACITY HFpEF)James E Udelson, Gregory D Lewis, Sanjiv J Shah, et al.
Circulation|January 22, 2025
Evidence-Based Application of Natriuretic Peptides in the Evaluation of Chronic Heart Failure With Preserved Ejection Fraction in the Ambulatory Outpatient SettingYogesh N V Reddy, Atsushi Tada, Masaru Obokata, et al.
JACC. Heart Failure|August 9, 2019
Circulating Neprilysin in Patients With Heart Failure and Preserved Ejection FractionMelissa A Lyle, Seethalakshmi R Iyer, Margaret M Redfield, et al.
Pageof 108